Back to WT Whittier Trust Co.
NTLA
Showing 3 of 25 quarters
Position history for WTWhittier Trust Co.'s holdings in Intellia Therapeutics, Inc.
No. Whittier Trust exited its NTLA (Intellia Therapeutics) position in Q1 2025. Its Q4 2024 13F listed 750 shares worth $8,744. Whittier Trust already held NTLA in its Q1 2019 13F, the earliest on record, and held it in 24 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$15,610
Total Shares Change
-760
Quarter-by-Quarter History